Differences in cardiovascular disease risk factor management in primary care by sex of physician and patient

Annals of Family Medicine

Volumn 8, Issue 1, 2010, Pages 25-32

  Tabenkin, Hava ^a,b   Eaton, Charles B ^c,d   Roberts, Mary B ^c   Parker, Donna R ^c,d   McMurray, Jerome H ^c   Borkan, Jeffrey ^c,d  

^a HAEMEK MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

Cardiovascular disease; Gender; Health disparities; Risk factors

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; DOCTOR PATIENT RELATION; FEMALE; GENERAL PRACTITIONER; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LOW CALORY DIET; MALE; OBESITY; PATIENT EDUCATION; PRACTICE GUIDELINE; SEX DIFFERENCE; UNITED STATES;

ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; CARDIOVASCULAR DISEASES; DIET, REDUCING; FEMALE; GUIDELINE ADHERENCE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; NEW ENGLAND; OBESITY; PATIENT EDUCATION AS TOPIC; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; PHYSICIANS, FAMILY; PRACTICE GUIDELINES AS TOPIC; SEX FACTORS;

EID: 77649164436     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.1071     Document Type: Article

References (47)

1. American Heart Association and the American Stroke Association. Heart Disease and Stroke Statistics-2005 Update. Dallas, TX: American Heart Association; 2005. http://www.americanheart.org.
2. US Department of Health and Human Services; National Institutes of Health; National Heart Lung and Blood Institute. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. NIH Publication No. 02-5215. Sep 2002:1-284.
3. Chobanian AV, Bakris GL, Black HR, et al.; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-2572.
4. Appel LJ, Champagne CM, Harsha DW, et al; Writing Group of the PREMIER Collaborative Research Group. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA. 2003;289(16):2083-2093.
5. Knopp RH, d'Emden M, Smilde JG, Pocock SJ. Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN). Diabetes Care. 2006;29(7):1478-1485.
6. Grundy SM, Cleeman JI, Merz LN. Heart, Lung and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Program Adults Treatment Panel III Guidelines. Circulation. 2004;110(2):227-239.
7. American Diabetes Association. Standards of medical care in diabetes-2006. Diabetes Care. 2006;29(Suppl 1):S4-S42.
8. Elmer PJ, Obarzanek E, Vollmer WM, et al.; PREMIER Collaborative Research Group. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med. 2006;144(7):485-495.
9. Correa-de-Araujo R, Stevens B, Moy E, Nilasena D, Chesley F, McDermott K. Gender differences across racial and ethnic groups in the quality of care for acute myocardial infarction and heart failure asso-ciated with comorbidities. Womens Health Issues. 2006;16(2):44-55.
10. Harrold LR, Lessard D, Yarzebski J, Gurwitz JH, Gore JM, Goldberg RJ. Age and sex differences in the treatment of patients with initial acute myocardial infarction: a community-wide perspective. Cardiology. 2003;99(1):39-46.
11. Kattainen A, Salomaa V, Jula A, et al. Gender differences in the treatment and secondary prevention of CHD at population level. Scand Cardiovasc J. 2005;39(6):327-333.
12. Gold LD, Krumholz HM. Gender differences in treatment of heart failure and acute myocardial infarction: a question of quality or epidemiology? Cardiol Rev. 2006;14(4):180-186.
13. Edwards ML, Albert NM, Wang C, Apperson-Hansen C. 1993 2003 gender differences in coronary artery revascularization: has anything changed? J Cardiovasc Nurs. 2005;20(6):461-467.
14. Jacobs AK. Women, ischemic heart disease, revascularization, and the gender gap: what we missing? J Am Coll Cardiol. 2006;47 (3 Suppl):63-65.
15. Abuful A, Gidron Y, Henkin Y. Physicians' attitudes toward preventive therapy for coronary artery disease: is there a gender bias? Clin Cardiol. 2005;28(8):389-393.
16. McBride SM, Flynn FW, Ren J. Cardiovascular alteration and treatment of hypertension: do men and women differ? Endocrine. 2005;28(2):199-207.
17. Kim C, Beckles GL. Cardiovascular disease risk reduction in the behavioral risk factor surveillance system. Am J Prev Med. 2004;27(1):1-7.
18. Goff DC Jr, Bertoni AG, Kramer H, et al. Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation. 2006;113(5):647-656.
19. Bittner V. Perspectives on dyslipidemia and coronary heart disease in women. J Am Coll Cardiol. 2005;46(9):1628-1635.
20. Trynosky KJ. Missed targets: gender differences in the identification and management of dyslipidemia. J Cardiovasc Nurs. 2006;21(5): 342-346.
21. Sarafidis PA, McFarlane SI, Bakris GL. Gender disparity in outcomes of care and management for diabetes and the metabolic syndrome. Curr Diab Rep. 2006;6(3):219-224.
22. Roter DL, Hall JA, Aoki Y. Physician gender effects in medical communication: a meta-analytic review. JAMA. 2002;288(6):756-764.
23. Kaplan SH, Greenfield S, Ware JE Jr. Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Med Care. 1989;27(3)(Suppl):S110-S127.
24. Kim C, Hofer TP, Kerr EA. Review of evidence and explanations for suboptimal screening and treatment of dyslipidemia in women. A conceptual model. J Gen Intern Med. 2003;18(10):854-863.
25. Street RL Jr, O'Malley KJ, Cooper LA, Haidet P. Understanding concordance in patient-physician relationships: personal and ethnic dimensions of shared identity. Ann Fam Med. 2008;6(3):198-205.
26. Boulis AK, Long JA. Gender differences in the practice of adult primary care physicians. J Womens Health. 2004;13(6):703-712.
27. Bertakis KD, Azari R. Patient gender and physician practice style. J Womens Health. 2007;16(6):859-868.
28. Tabenkin H, Goodwin MA, Zyzanski SJ, Stange KC, Medalie JH. Gender differences in time spent during direct observation of doctor-patient encounters. J Womens Health (Larchmt). 2004;13(3):341-349.
29. Franks P, Bertakis KD. Physician gender, patient gender and primary care. J Womens Health (Larchmt) 2003;12(1):73-80.
30. Lurie N, Slater J, McGovern P, Ekstrum J, Quam L, Margolis K. Preventive care for women. Does the sex of the physician matter? N Engl J Med. 1993;329(7):478-482.
31. Kreuter MW, Strecher VJ, Harris R, Kobrin SC, Skinner CS. Are patients of women physicians screened more aggressively? A prospective study of physician gender and screening. J Gen Intern Med. 1995;10(3):119-125.
32. Schmittdiel J, Grumbach K, Selby JV, Quesenberry CP Jr. Effect of physician and patient gender concordance on patient satisfaction and preventive care practices. J Gen Intern Med. 2000;15(11): 761-769.
33. Henderson JT, Weisman CS. Physician gender effects on preventive screening and counseling: an analysis of male and female patients' health care experiences. Med Care. 2001;39(12):1281-1292.
34. Flocke SA, Gilchrist V. Physician and patient gender concordance and the delivery of comprehensive clinical preventive services. Med Care. 2005;43(5):486-492.
35. Kim C, McEwen LN, Gerzoff RB, et al. Is physician gender associated with the quality of diabetes care? Diabetes Care. 2005;28(7): 1594-1598.
36. Berthold HK, Gouni-Berthold I, Bestehorn KP, Böhm M, Krone W. Physician gender is associated with the quality of type 2 diabetes care. J Intern Med. 2008;264(4):340-350.
37. Schappert SM. National Ambulatory medical care survey: 1994 summary. Advance data from vital and health statistics. Adv Data. 1996;273(273):1-18.
38. United States Department of Health and Human Services. OCR Privacy Brief. Summary of the HIPAA Privacy Rule. http://www.hhs.gov/ocr/privacysummary.pdf. Accessed Nov 10, 2008.
39. Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol. 1989;129(1):125-137.
40. Nguyen KX, Marinac JS, Sun C. Aspirin for primary prevention in patients with diabetes mellitus. Fam Med. 2005;37(2):112-117.
41. Cull CA, Neil HAW, Holman RR. Changing aspirin use in patients with Type 2 diabetes in the UKPDS. Diabet Med. 2004;21(12):1368-1371.
42. Petri A, de Lusignan S, Williams J, Chan T, Majeed A. Management of cardiovascular risk factors in people with diabetes in primary care: cross-sectional study. Public Health. 2006;120(7):654-663.
43. Wexler DJ, Grant RW, Meigs JB, Nathan DM, Cagliero E. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care. 2005;28(3):514-520.
44. Roter DL, Hall JA. How physician gender shapes the communication and evaluation of medical care. Mayo Clin Proc. 2001;76(7):673-676.
45. Allende-Vigo MZ. Cardiovascular disease in women with diabetes mellitus: a review. P R Health Sci J. 2004;23(3):193-197.
46. Egede LE, Zheng D. Modifiable cardiovascular risk factors in adults with diabetes: prevalence and missed opportunities for physician counseling. Arch Intern Med. 2002;162(4):427-433.
47. Hayes N Sh, Taler SJ. Hypertension in women: Current understanding of gender differences. Mayo Clin Proc. 1998;73(2):157-165.